As the unusually cool summer on the west coast of North America
starts to wind down, the Erowid crew is gearing up for the busier
coming months. With the news of visionary artist Robert Venosa's
death at 75 last week, we are again moved to remember the many elders
in our field who have lead the way and the importance of trying to
preserve their collected wisdom before it dissipates into the winds
of passing years. Thanks to everyone who contributes to the evolution
of knowledge about psychoactives.
In History...25 Years Ago Today
Twenty-five years ago, the psychoactive drug zeitgeist was dominated
by the crack-cocaine scourge, a control controversy around MDMA, and
the growing issue of "designer drugs". In May 1986, an administrative
judge ruled that the DEA's adding of MDMA to Schedule I was invalid,
triggering legal battles. In June, at the height of the Reagan-era
crack cocaine explosion, basketball player Len Bias's cocaine-related
death was a major media event. In August 1986, Discover magazine
published "Beyond Crack: The Growing Peril of Designer Drugs" and
Good Housekeeping published "Crack: Dangerous New Drug".
Events
Earth and Fire will be speaking at the Entheogenesis Australis
Conference (Dec 2 - 5, 2011)
north of Melbourne, Australia. Come join us at this three-day outdoor event! http://www.entheo.net/ Latest Additions
Crew Notes
In July, the DEA published a Federal Register (FR) entry denying a
petition to reschedule cannabis. Curiously, there are two distinct
voices in the publication, one from the Department of Health and
Human Services (DHHS) and one from the DEA. This FR entry includes
discussion of the linkage between cannabis use and psychosis, with
the DHHS stating "At present, the data do not suggest a causative
link between marijuana use and the development of psychosis." Later
in the entry, the DEA rebuts this, arguing that evidence does show a
causal connection. An amusing (yet disturbing) dispute between the
scientific body (the DHHS) and the political/police body (the DEA).
Another interesting point about this document is it appears to offer a formalized view by both DHHS and the DEA that cannabis is not a "gateway drug". http://www.deadiversion.usdoj.gov/fed_regs/rules/2011/fr0708.htm From the Vaults
More New Content
Experience Reports
(see 140 new) Ecstasy Data
(see 23 new results)
EcstasyData is a project of Erowid Center that conducts laboratory
testing of street Ecstasy tablets and publishes these and other test
results online.
Donate Or Become A Member
If you find Erowid a useful resource and are interested in supporting
its future development, please consider donating or becoming a member.
Donations to Erowid Center are tax-deductible in the United States.
List Subscription Information
|